Skip to search formSkip to main contentSkip to account menu

CER-001

National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Apolipoprotein A-IPhospholipidsRecombinant Proteins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Clinical tolerability and safety profile of CER-001, a novel bio-engineered pre-β HDL-mimetic, across the clinical development programme
2015
2015
Abstract 12156: Greater Regression of Coronary Atherosclerosis With the Pre-Beta High-Density Lipoprotein Mimetic CER-001 in Patients With More Extensive Plaque Burden
Introduction: Infusing high-density lipoprotein (HDL) has been shown to promote plaque regression in patients with acute coronary… 
2014
2014
Effect of open-label infusion of an apolipoprotein A-I-containing particle ( CER-001 ) on reverse cholesterol transport and artery wall thickness in patients with familial hypo-alphalipoproteinemia
  • 2014
  • Corpus ID: 6058876
Background Reverse cholesterol transport (RCT) contributes to the anti-atherogenic effects of High-density lipoprotein (HDL… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)